Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

6 projects found matching your search criteria :

  1. The role of 5-hydroxymethyluracil in chronic lymphocytic leukemia development

    Call: PRELUDIUM BIS 2 , Panel: NZ5

    Principal investigator: dr hab. Daniel Gackowski

    Uniwersytet Mikołaja Kopernika w Toruniu, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Wydział Farmaceutyczny

  2. Investigation of involvement of particular TET protein family members in the generation of epigenetic DNA modyfications.

    Call: PRELUDIUM 15 , Panel: NZ1

    Principal investigator: Maciej Gawroński

    Uniwersytet Mikołaja Kopernika w Toruniu, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Wydział Farmaceutyczny

  3. Fast and non-invasive peri-transplant assessment of human liver grafts subjected to hypo- and normothermic perfusion

    Call: OPUS 21 , Panel: NZ5

    Principal investigator: dr hab. Barbara Bojko

    Uniwersytet Mikołaja Kopernika w Toruniu, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Wydział Farmaceutyczny

  4. The applicability of Coated Blade Spray coupled with mass spectrometry for the analysis endogenous substances in meningi...

    Call: PRELUDIUM 17 , Panel: ST4

    Principal investigator: Joanna Bogusiewicz

    Uniwersytet Mikołaja Kopernika w Toruniu, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Wydział Farmaceutyczny

  5. Uracil in DNA and aberrant DNA methylation/hydroxymethylation as a new biomarkers of multiple myeloma development? A sea...

    Call: OPUS 20 , Panel: NZ5

    Principal investigator: prof. Ryszard Oliński

    Uniwersytet Mikołaja Kopernika w Toruniu, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Wydział Farmaceutyczny

  6. New analytical tools based on thin-film microextraction for the search and determination of biliary biomarkers of early ...

    Call: PRELUDIUM 21 , Panel: ST4

    Principal investigator: Kamil Łuczykowski

    Uniwersytet Mikołaja Kopernika w Toruniu, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Wydział Farmaceutyczny